
Dow Surged 3%, Gilead Sciences (GILD) Stock Up 10%, Remdesivir Helps Coronavirus Patients
Researchers from the University of Chicago Medicine have given a potential breakthrough showing fast recovery for 125 COVID-19 patients by using the Remdesivir drug from Gilead Sciences. GILD stock is 10% up.